Stephen Mandel
Lone Pine Capital
Lone Pine Capital Portfolio 13F
Stephen Mandel Holdings Activity
- Portfolio value:
- $27.51B≈ (+$4B≈)
- Previous value:
- $23.28B≈
- # of changes:
- 46
- New positions:
- 15
- Reported for:
- 31 Dec 2020 (Q4)
- Latest filing date:
- 16 Feb 2021
Lone Pine Capital has disclosed a total of 46 changes to the portfolio in the (2020 Q4) SEC report(s): increased the number of shares of 10, bought 15 totally new, decreased the number of shares of 15 and completely sold out 6 position(s).
What stocks did Stephen Mandel buy in 2020 Q4?
During 2020 Q4 Stephen Mandel has bought 25 securities out of which top 5 purchases (by % change to portfolio) were (SHOP) Shopify Inc (added shares +4.22%), (NFLX) Netflix Inc (added shares +8.92%), (ADBE) Adobe Systems Incorporated (added shares +19.60%), (MELI) MercadoLibre Inc (added shares +179.54%) and (SNAP) Snap Inc (new buy).
In the 2020 Q4 report(s) the following changes have been made to the top investments: (SHOP) Shopify Inc (added shares +4.22%), (COUP) Coupa Software Inc (reduced shares -2.51%), (MSFT) Microsoft Corp (reduced shares -1.99%), (GPN) Global Payments Inc (reduced shares -1.00%) and (NFLX) Netflix Inc (added shares +8.92%).
46 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Amicus Therapeutics Inc
|
new
|
$23.09
|
|
0.56%
|
2020 Q4
|
≈ 0.25 years
|
||||
|
|
argenx NV ADR
|
new
|
$294.09
|
+183.55%($833.89)
|
0.57%
|
2020 Q4
|
≈ 0.25 years
|
||||
|
|
Ascendis Pharma AS
|
new
|
$166.78
|
+46.87%($244.95)
|
0.54%
|
2020 Q4
|
≈ 0.25 years
|
||||
|
|
Bilibili Inc
|
new
|
$85.72
|
-77.37%($19.40)
|
1.87%
|
2020 Q4
|
≈ 0.25 years
|
||||
|
|
Blueprint Medicines Corp
|
new
|
$112.15
|
|
1.10%
|
2020 Q4
|
≈ 0.25 years
|
||||
|
|
Carvana Co
|
new
|
$239.54
|
-73.07%($64.52)
|
2.13%
|
2020 Q4
|
≈ 0.25 years
|
||||
|
|
DoorDash, Inc, CL-A
|
new
|
$142.75
|
+40.97%($201.23)
|
1.17%
|
2020 Q4
|
≈ 0.25 years
|
||||
|
|
FARFETCH LTD, CL-A
|
new
|
$63.81
|
-100.00%($0.00)
|
1.87%
|
2020 Q4
|
≈ 0.25 years
|
||||
|
|
Fate Therapeutics Inc
|
new
|
$90.93
|
-97.26%($2.50)
|
0.29%
|
2020 Q4
|
≈ 0.25 years
|
||||
|
|
Fidelity National Information Services Inc
|
new
|
$141.46
|
-68.20%($44.98)
|
1.44%
|
2020 Q4
|
≈ 0.25 years
|
||||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.